Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Perlegen Sciences brings in $30mm with Series C round

Executive Summary

Genomics company Perlegen Sciences Inc. (an affiliate of Affymetrix) genomics division raised $30mm in a Series C private placement led by Maverick Capital. Other new investors Biofrontier Partners, CSK Venture Capital, Unilever Technology Ventures, and Eli Lilly & Co. were joined by returning investors Biomedical Sciences Investment Fund, CMEA Ventures, SB Life Science Ventures, Vulcan Ventures, and Dr. Alejandro Zaffaroni, the company's founder.
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies